SEARCH

SEARCH BY CITATION

References

  • 1
    White H.D. Norris R.M. Brown M.A. Brandt P.W. Whitlock R.M. Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction Circulation 1987 76 44 51
  • 2
    Pfeffer M.A. Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications Circulation 1990 81 1161 1172
  • 3
    Mori S. Gibson G. McTiernan C.F. Differential expression of MMPs and TIMPs in moderate and severe heart failure in a transgenic model J Card Fail 2006 12 314 325
  • 4
    Ducharme A. Frantz S. Aikawa M. et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction J Clin Invest 2000 106 55 62
  • 5
    Romanic A.M. Burns-Kurtis C.L. Gout B. Berrebi-Bertrand I. Ohlstein E.H. Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit Life Sci 2001 68 799 814
  • 6
    Samnegard A. Silveira A. Tornvall P. Hamsten A. Ericsson C.G. Eriksson P. Lower serum concentration of matrix metalloproteinase-3 in the acute stage of myocardial infarction J Intern Med 2006 259 530 536
  • 7
    Squire I.B. Evans J. Ng L.L. Loftus I.M. Thompson M.M. Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction J Card Fail 2004 10 328 333
  • 8
    Kelly D. Cockerill G. Ng L.L. et al. Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study Eur Heart J 2007 28 711 718
  • 9
    Webb C.S. Bonnema D.D. Ahmed S.H. et al. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling Circulation 2006 114 1020 1027
  • 10
    Spinale F.G. Coker M.L. Thomas C.V. Walker J.D. Mukherjee R. Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function Circ Res 1998 82 482 495
  • 11
    Tziakas D.N. Chalikias G.K. Papaioakeim M. et al. Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy Am J Cardiol 2005 96 1449 1451
  • 12
    Mizon-Gerard F. de Groote P. Lamblin N. et al. Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction Eur Heart J 2004 25 688 693
  • 13
    George J. Patal S. Wexler D. Roth A. Sheps D. Keren G. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure Am Heart J 2005 150 484 487
  • 14
    Rohde L.E. Ducharme A. Arroyo L.H. et al. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice Circulation 1999 99 3063 3070
  • 15
    Spinale F.G. Coker M.L. Krombach S.R. et al. Matrix metalloproteinase inhibition during the development of congestive heart failure: effects on left ventricular dimensions and function Circ Res 1999 85 364 376
  • 16
    Lindsey M.L. Gannon J. Aikawa M. et al. Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction Circulation 2002 105 753 758
  • 17
    Hudson M.P. Armstrong P.W. Ruzyllo W. et al. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial J Am Coll Cardiol 2006 48 15 20
  • 18
    Saglam M. Karakaya O. Esen A.M. et al. Contribution of plasma matrix metalloproteinases to development of left ventricular hypertrophy and diastolic dysfunction in hypertensive subjects Tohoku J Exp Med 2006 208 117 122
  • 19
    Fielitz J. Leuschner M. Zurbrugg H.R. et al. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis J Mol Med 2004 82 809 820
  • 20
    Walther T. Schubert A. Falk V. et al. Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression Circulation 2001 104 I54 I58